{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:04:27Z","timestamp":1772625867353,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54-NS100693"],"award-info":[{"award-number":["U54-NS100693"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008539","name":"CurePSP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008539","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mitochondrial health is important in ageing and dysfunctional oxidative phosphorylation (OXPHOS) accelerates ageing and influences neurodegeneration. Mitochondrial DNA (mtDNA) codes for vital OXPHOS subunits and mtDNA background has been associated with neurodegeneration; however, no study has characterised mtDNA variation in Progressive supranuclear palsy (PSP) or Corticobasal degeneration (CBD) risk or pathogenesis. In this case\u2013control study, 910 (42.6% male) neurologically-healthy controls, 1042 (54.1% male) pathologically-confirmed PSP cases, and 171 (52.0% male) pathologically-confirmed CBD cases were assessed to determine how stable mtDNA polymorphisms, in the form of mtDNA haplogroups, were associated with risk of PSP, risk of CBD, age of PSP onset, PSP disease duration, and neuropathological tau pathology measures for neurofibrillary tangles (NFT), neuropil threads (NT), tufted astrocytes (TA), astrocytic plaques (AP), and oligodendroglial coiled bodies (CB). 764 PSP cases and 150 CBD cases had quantitative tau pathology scores. mtDNA was genotyped for 39 unique SNPs using Agena Bioscience iPlex technologies and mitochondrial haplogroups were defined to mitochondrial phylogeny. After adjustment for multiple testing, we observed an association with risk of CBD for mtDNA sub-haplogroup H4 (OR\u2009=\u20094.51, P\u2009=\u20090.001) and the HV\/HV0a haplogroup was associated with a decreased severity of NT tau pathology in PSP cases (P\u2009=\u20090.0023). Our study reports that mitochondrial genomic background may be associated with risk of CBD and may be influencing tau pathology measures in PSP. Replication of these findings will be important.<\/jats:p>","DOI":"10.1186\/s40478-020-01035-z","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T10:15:20Z","timestamp":1600337720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures"],"prefix":"10.1186","volume":"8","author":[{"given":"Rebecca R.","family":"Valentino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikoleta","family":"Tamvaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Heckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra I.","family":"Soto-Beasley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald L.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan J.","family":"Uitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbigniew K.","family":"Wszolek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4813-756X","authenticated-orcid":false,"given":"Owen A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"issue":"9192","key":"1035_CR1","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","volume":"354","author":"A Schrag","year":"1999","unstructured":"Schrag A, Ben-Shlomo Y, Quinn NP (1999) Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. The Lancet 354(9192):1771\u20131775","journal-title":"The Lancet"},{"key":"1035_CR2","first-page":"457","volume-title":"The Epidemiology of Progressive Supranuclear Palsy","author":"LI Golbe","year":"2008","unstructured":"Golbe LI (2008) The Epidemiology of Progressive Supranuclear Palsy. Elsevier, Handbook of Clinical Neurology, pp 457\u2013459"},{"issue":"7","key":"1035_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","volume":"16","author":"AL Boxer","year":"2017","unstructured":"Boxer AL, Yu J-T, Golbe LI, Litvan I, Lang AE, H\u00f6glinger GU (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16(7):552\u2013563","journal-title":"Lancet Neurol"},{"issue":"5","key":"1035_CR4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/brain\/112.5.1171","volume":"112","author":"WRG Gibb","year":"1989","unstructured":"Gibb WRG, Luthert PJ, Marsden CD (1989) Corticobasal degeneration. Brain 112(5):1171\u20131192","journal-title":"Brain"},{"issue":"8","key":"1035_CR5","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1212\/WNL.40.8.1203","volume":"40","author":"DE Riley","year":"1990","unstructured":"Riley DE, Lang AE, Lewis A, Resch L, Ashby P, Hornykiewicz O, Black S (1990) Cortical-basal ganglionic degeneration. Neurology 40(8):1203\u20131212","journal-title":"Neurology"},{"issue":"2","key":"1035_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neulet.2011.01.020","volume":"491","author":"BN Dugger","year":"2011","unstructured":"Dugger BN, Tu M, Murray ME, Dickson DW (2011) Disease specificity and pathologic progression of tau pathology in brainstem nuclei of Alzheimer\u2019s disease and progressive supranuclear palsy. Neurosci Lett 491(2):122\u2013126","journal-title":"Neurosci Lett"},{"issue":"22","key":"1035_CR7","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1212\/WNL.0b013e318294b2eb","volume":"80","author":"S Fujioka","year":"2013","unstructured":"Fujioka S, Algom AA, Murray ME, Strongosky A, Soto-Ortolaza AI, Rademakers R, Ross OA, Wszolek ZK, Dickson DW (2013) Similarities between familial and sporadic autopsy-proven progressive supranuclear palsy. Neurology 80(22):2076\u20132078","journal-title":"Neurology"},{"issue":"6","key":"1035_CR8","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"U H\u00f6glinger G\u00fcnter","year":"2017","unstructured":"H\u00f6glinger G\u00fcnter U, Respondek G, Stamelou M, Kurz C, Josephs Keith A, Lang Anthony E, Mollenhauer B, M\u00fcller U, Nilsson C, Whitwell Jennifer L, Arzberger T, Englund E, Gelpi E, Giese A, Irwin David J, Meissner Wassilios G, Pantelyat A, Rajput A, Swieten John C, Troakes C, Antonini A, Bhatia Kailash P, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson Dennis W, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris Huw R, Nestor P, Oertel Wolfgang H, Poewe W, Rabinovici G, Rowe James B, Schellenberg Gerard D, Seppi K, Eimeren T, Wenning Gregor K, Boxer Adam L, Golbe Lawrence I, Litvan I, Null N, Boxer Adam L, Rajput A, Pantelyat A, Antonini A, Lang Anthony E, Giese A, Mollenhauer B, Colosimo C, Kurz C, Nilsson C, Troakes C, Irwin David J, Dickson Dennis W, Gelpi E, Krismer F, Schellenberg Gerard D, Respondek G, Rabinovici G, Wenning Gregor K, H\u00f6glinger G\u00fcnter U, Morris Huw R, Litvan I, Rowe James B, Kassubek J, Corvol JC, Whitwell Jennifer L, Levin J, van Swieten J, Bhatia Kailash P, Josephs Keith A, Seppi K, Golbe Lawrence I, Stamelou M, Grossman M, Nestor P, Dodel R, Lorenzl S, van Eimeren T, Arzberger T, M\u00fcller U, Meissner Wassilios G, Poewe W, Oertel Wolfgang H, Compta Y, Bordelon Y (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32(6):853\u2013864","journal-title":"Mov Disord"},{"issue":"2","key":"1035_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/BF03161076","volume":"246","author":"DW Dickson","year":"1999","unstructured":"Dickson DW (1999) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246(2):6\u201315","journal-title":"J Neurol"},{"issue":"11","key":"1035_CR10","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","volume":"61","author":"DW Dickson","year":"2002","unstructured":"Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I (2002) Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61(11):935\u2013946","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"1035_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-018-0267-3","volume":"13","author":"MY Sanchez-Contreras","year":"2018","unstructured":"Sanchez-Contreras MY, Kouri N, Cook CN, Serie DJ, Heckman MG, Finch NA, Caselli RJ, Uitti RJ, Wszolek ZK, Graff-Radford N, Petrucelli L, Wang L-S, Schellenberg GD, Dickson DW, Rademakers R, Ross OA (2018) Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci. Mol Neurodegener 13(1):37","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1035_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12208","volume":"41","author":"GG Kovacs","year":"2015","unstructured":"Kovacs GG (2015) Invited review: Neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol 41(1):3\u201323","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"1035_CR13","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s12031-011-9606-3","volume":"45","author":"V Ries","year":"2011","unstructured":"Ries V, Oertel WH, H\u00f6glinger GU (2011) Mitochondrial dysfunction as a therapeutic target in progressive supranuclear palsy. J Mol Neurosci 45(3):684","journal-title":"J Mol Neurosci"},{"key":"1035_CR14","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.1038\/ncomms8247","volume":"6","author":"N Kouri","year":"2015","unstructured":"Kouri N, Ross OA, Dombroski B, Younkin CS, Serie DJ, Soto-Ortolaza A, Baker M, Finch NCA, Yoon H, Kim J, Fujioka S, McLean CA, Ghetti B, Spina S, Cantwell LB, Farlow MR, Grafman J, Huey ED, Ryung Han M, Beecher S, Geller ET, Kretzschmar HA, Roeber S, Gearing M, Juncos JL, Vonsattel JPG, Van Deerlin VM, Grossman M, Hurtig HI, Gross RG, Arnold SE, Trojanowski JQ, Lee VM, Wenning GK, White CL, H\u00f6glinger GU, M\u00fcller U, Devlin B, Golbe LI, Crook J, Parisi JE, Boeve BF, Josephs KA, Wszolek ZK, Uitti RJ, Graff-Radford NR, Litvan I, Younkin SG, Wang L-S, Ertekin-Taner N, Rademakers R, Hakonarsen H, Schellenberg GD, Dickson DW (2015) Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy. Nat Commun 6:7247","journal-title":"Nat Commun"},{"issue":"6","key":"1035_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1001\/jamaneurol.2019.0250","volume":"76","author":"MG Heckman","year":"2019","unstructured":"Heckman MG, Brennan RR, Labb\u00e9 C, Soto AI, Koga S, DeTure MA, Murray ME, Petersen RC, Boeve BF, van Gerpen JA, Uitti RJ, Wszolek ZK, Rademakers R, Dickson DW, Ross OA (2019) Association of MAPT subhaplotypes with risk of progressive supranuclear palsy and severity of tau pathology. JAMA Neurol 76(6):710\u2013717","journal-title":"JAMA Neurol"},{"issue":"1","key":"1035_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-018-0270-8","volume":"13","author":"JA Chen","year":"2018","unstructured":"Chen JA, Chen Z, Won H, Huang AY, Lowe JK, Wojta K, Yokoyama JS, Bensimon G, Leigh PN, Payan C, Shatunov A, Jones AR, Lewis CM, Deloukas P, Amouyel P, Tzourio C, Dartigues JF, Ludolph A, Boxer AL, Bronstein JM, Al-Chalabi A, Geschwind DH, Coppola G (2018) Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases. Mol Neurodegener 13(1):41","journal-title":"Mol Neurodegener"},{"issue":"11","key":"1035_CR17","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.bbabio.2015.05.015","volume":"1847","author":"MJ Keogh","year":"2015","unstructured":"Keogh MJ, Chinnery PF (2015) Mitochondrial DNA mutations in neurodegeneration. Biochim Biophys Acta Bioenergetics 1847(11):1401\u20131411","journal-title":"Biochim Biophys Acta Bioenergetics"},{"issue":"1","key":"1035_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1006\/exnr.2000.7607","volume":"168","author":"DS Albers","year":"2001","unstructured":"Albers DS, Swerdlow RH, Manfredi G, Gajewski C, Yang L, Parker WD Jr, Beal MF (2001) Further evidence for mitochondrial dysfunction in progressive supranuclear palsy. Exp Neurol 168(1):196\u2013198","journal-title":"Exp Neurol"},{"issue":"10","key":"1035_CR19","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1023\/A:1025682611389","volume":"28","author":"AC Rego","year":"2003","unstructured":"Rego AC, Oliveira CR (2003) Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem Res 28(10):1563\u20131574","journal-title":"Neurochem Res"},{"issue":"4","key":"1035_CR20","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1046\/j.1471-4159.2000.0751681.x","volume":"75","author":"RH Swerdlow","year":"2000","unstructured":"Swerdlow RH, Golbe LI, Parks JK, Cassarino DS, Binder DR, Grawey AE, Litvan I, Bennett JP Jr, Wooten GF, Parker WD (2000) Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy. J Neurochem 75(4):1681\u20131684","journal-title":"J Neurochem"},{"key":"1035_CR21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.redox.2017.10.016","volume":"14","author":"PR Angelova","year":"2018","unstructured":"Angelova PR, Barilani M, Lovejoy C, Dossena M, Vigan\u00f2 M, Seresini A, Piga D, Gandhi S, Pezzoli G, Abramov AY, Lazzari L (2018) Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation. Redox Biol 14:474\u2013484","journal-title":"Redox Biol"},{"issue":"9","key":"1035_CR22","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1096\/fj.201700170R","volume":"31","author":"J Roy","year":"2017","unstructured":"Roy J, Galano J-M, Durand T, Guennec J-YL, Lee JC-Y (2017) Physiological role of reactive oxygen species as promoters of natural defenses. FASEB J 31(9):3729\u20133745","journal-title":"FASEB J"},{"issue":"12","key":"1035_CR23","doi-asserted-by":"publisher","first-page":"11648","DOI":"10.1074\/jbc.M414327200","volume":"280","author":"J Choi","year":"2005","unstructured":"Choi J, Rees HD, Weintraub ST, Levey AI, Chin L-S, Li L (2005) Oxidative modifications and aggregation of Cu, Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. J Biol Chem 280(12):11648\u201311655","journal-title":"J Biol Chem"},{"issue":"12","key":"1035_CR24","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S0891-5849(02)00804-3","volume":"32","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Ischiropoulos H, Lee VMY, Trojanowski JQ (2002) The relationship between oxidative\/nitrative stress and pathological inclusions in Alzheimer\u2019s and Parkinson\u2019s diseases 1,211 Guest Editors: Mark A. Smith and George Perry22. This article is part of a series of reviews on \u201cCauses and Consequences of Oxidative Stress in Alzheimer\u2019s Disease\u201d. Free Radic Biol Med 32(12):1264\u20131275","journal-title":"Free Radic Biol Med"},{"issue":"S3","key":"1035_CR25","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1002\/ana.10483","volume":"53","author":"P Jenner","year":"2003","unstructured":"Jenner P (2003) Oxidative stress in Parkinson\u2019s disease. Ann Neurol 53(S3):S26\u2013S38","journal-title":"Ann Neurol"},{"issue":"11","key":"1035_CR26","doi-asserted-by":"publisher","first-page":"e113070","DOI":"10.1371\/journal.pone.0113070","volume":"9","author":"J Bruch","year":"2014","unstructured":"Bruch J, Xu H, De Andrade A, H\u00f6glinger G (2014) Mitochondrial complex 1 inhibition increases 4-repeat isoform tau by SRSF2 upregulation. PLoS ONE 9(11):e113070","journal-title":"PLoS ONE"},{"issue":"3","key":"1035_CR27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"AHV Schapira","year":"1990","unstructured":"Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990) Mitochondrial complex I deficiency in Parkinson\u2019s disease. J Neurochem 54(3):823\u2013827","journal-title":"J Neurochem"},{"issue":"1","key":"1035_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13041-017-0340-9","volume":"10","author":"L Puspita","year":"2017","unstructured":"Puspita L, Chung SY, Shim J-W (2017) Oxidative stress and cellular pathologies in Parkinson\u2019s disease. Mol Brain 10(1):53","journal-title":"Mol Brain"},{"issue":"5","key":"1035_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.mito.2012.10.011","volume":"13","author":"AN Malik","year":"2013","unstructured":"Malik AN, Czajka A (2013) Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction? Mitochondrion 13(5):481\u2013492","journal-title":"Mitochondrion"},{"issue":"17","key":"1035_CR30","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1093\/hmg\/ddq246","volume":"19","author":"A G\u00f3mez-Dur\u00e1n","year":"2010","unstructured":"G\u00f3mez-Dur\u00e1n A, Pacheu-Grau D, L\u00f3pez-Gallardo E, D\u00edez-S\u00e1nchez C, Montoya J, L\u00f3pez-P\u00e9rez MJ, Ruiz-Pesini E (2010) Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum Mol Genet 19(17):3343\u20133353","journal-title":"Hum Mol Genet"},{"key":"1035_CR31","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3389\/fnins.2018.00682","volume":"12","author":"PF Chinnery","year":"2018","unstructured":"Chinnery PF, Gomez-Duran A (2018) Oldies but goldies mtDNA population variants and neurodegenerative diseases. Front Neurosci 12:682","journal-title":"Front Neurosci"},{"issue":"4","key":"1035_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10038-008-0259-1","volume":"53","author":"H Latsoudis","year":"2008","unstructured":"Latsoudis H, Spanaki C, Chlouverakis G, Plaitakis A (2008) Mitochondrial DNA polymorphisms and haplogroups in Parkinson\u2019s disease and control individuals with a similar genetic background. J Hum Genet 53(4):349\u2013356","journal-title":"J Hum Genet"},{"issue":"6","key":"1035_CR33","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/sj.ejhg.5201425","volume":"13","author":"D Ghezzi","year":"2005","unstructured":"Ghezzi D, Marelli C, Achilli A, Goldwurm S, Pezzoli G, Barone P, Pellecchia MT, Stanzione P, Brusa L, Bentivoglio AR, Bonuccelli U, Petrozzi L, Abbruzzese G, Marchese R, Cortelli P, Grimaldi D, Martinelli P, Ferrarese C, Garavaglia B, Sangiorgi S, Carelli V, Torroni A, Albanese A, Zeviani M (2005) Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson\u2019s disease in Italians. Eur J Hum Genet 13(6):748\u2013752","journal-title":"Eur J Hum Genet"},{"issue":"9","key":"1035_CR34","doi-asserted-by":"publisher","first-page":"e45134","DOI":"10.1371\/journal.pone.0045134","volume":"7","author":"PG Ridge","year":"2012","unstructured":"Ridge PG, Maxwell TJ, Corcoran CD, Norton MC, Tschanz JT, O\u2019Brien E, Kerber RA, Cawthon RM, Munger RG, Kauwe JSK (2012) Mitochondrial genomic analysis of late onset Alzheimer\u2019s disease reveals protective haplogroups H6A1A\/H6A1B: the cache county study on memory in aging. PLoS ONE 7(9):e45134","journal-title":"PLoS ONE"},{"issue":"1","key":"1035_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00005072-199601000-00010","volume":"55","author":"I Litvan","year":"1996","unstructured":"Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson DW (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55(1):97\u2013105","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"1035_CR36","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/mds.27198","volume":"32","author":"S Koga","year":"2017","unstructured":"Koga S, Parks A, Kasanuki K, Sanchez-Contreras M, Baker MC, Josephs KA, Ahlskog JE, Uitti RJ, Graff-Radford N, van Gerpen JA, Wszolek ZK, Rademakers R, Dickson DW (2017) Cognitive impairment in progressive supranuclear palsy is associated with tau burden. Movement Disord 32(12):1772\u20131779","journal-title":"Movement Disord"},{"issue":"4","key":"1035_CR37","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1750-3639.1999.tb00550.x","volume":"9","author":"L Bu\u00e9e","year":"1999","unstructured":"Bu\u00e9e L, Delacourte A (1999) Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick\u2019s disease. Brain Pathol (Zurich, Switzerland) 9(4):681\u2013693","journal-title":"Brain Pathol (Zurich, Switzerland)"},{"issue":"6","key":"1035_CR38","first-page":"1531","volume":"152","author":"M P\u00e9rez","year":"1998","unstructured":"P\u00e9rez M, Valpuesta JM, de Garcini EM, Quintana C, Arrasate M, L\u00f3pez Carrascosa JL, R\u00e1bano A, Garc\u00eda de Y\u00e9benes J, Avila J (1998) Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy. Am J Pathol 152(6):1531\u20131539","journal-title":"Am J Pathol"},{"issue":"3","key":"1035_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3233\/JAD-2006-9307","volume":"9","author":"I Santa-Mar\u00eda","year":"2006","unstructured":"Santa-Mar\u00eda I, P\u00e9rez M, Hern\u00e1ndez F, Avila J, Moreno FJ (2006) Characteristics of the binding of thioflavin S to tau paired helical filaments. J Alzheimers Dis 9(3):279\u2013285","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1035_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239\u2013259","journal-title":"Acta Neuropathol"},{"issue":"12","key":"1035_CR41","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H (2002) Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD. Neurology 58(12):1791\u20131800","journal-title":"Neurology"},{"issue":"Pt 5","key":"1035_CR42","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/brain\/awv050","volume":"138","author":"ME Murray","year":"2015","unstructured":"Murray ME, Lowe VJ, Graff-Radford NR, Liesinger AM, Cannon A, Przybelski SA, Rawal B, Parisi JE, Petersen RC, Kantarci K, Ross OA, Duara R, Knopman DS, Jack CR Jr, Dickson DW (2015) Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer\u2019s disease spectrum. Brain 138(Pt 5):1370\u20131381","journal-title":"Brain"},{"issue":"1","key":"1035_CR43","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1038\/s41467-018-06783-0","volume":"9","author":"N Zhao","year":"2018","unstructured":"Zhao N, Liu C-C, Van Ingelgom AJ, Linares C, Kurti A, Knight JA, Heckman MG, Diehl NN, Shinohara M, Martens YA, Attrebi ON, Petrucelli L, Fryer JD, Wszolek ZK, Graff-Radford NR, Caselli RJ, Sanchez-Contreras MY, Rademakers R, Murray ME, Koga S, Dickson DW, Ross OA, Bu G (2018) APOE \u03b52 is associated with increased tau pathology in primary tauopathy. Nature Communications 9(1):4388","journal-title":"Nature Communications"},{"issue":"1","key":"1035_CR44","first-page":"2.12.1","volume":"60","author":"S Gabriel","year":"2009","unstructured":"Gabriel S, Ziaugra L, Tabbaa D (2009) SNP genotyping using the sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet 60(1):2.12.1\u20132.12.18","journal-title":"Curr Protoc Hum Genet"},{"issue":"2","key":"1035_CR45","doi-asserted-by":"publisher","first-page":"E386","DOI":"10.1002\/humu.20921","volume":"30","author":"M van Oven","year":"2009","unstructured":"van Oven M, Kayser M (2009) Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat 30(2):E386\u2013E394","journal-title":"Hum Mutat"},{"issue":"123","key":"1035_CR46","first-page":"1","volume":"44","author":"MT Lott","year":"2013","unstructured":"Lott MT, Leipzig JN, Derbeneva O, Xie HM, Chalkia D, Sarmady M, Procaccio V, Wallace DC (2013) mtDNA variation and analysis using mitomap and mitomaster. Curr Protoc Bioinform 44(123):1\u201326","journal-title":"Curr Protoc Bioinform"},{"issue":"4","key":"1035_CR47","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/genetics\/144.4.1835","volume":"144","author":"A Torroni","year":"1996","unstructured":"Torroni A, Huoponen K, Francalacci P, Petrozzi M, Morelli L, Scozzari R, Obinu D, Savontaus ML, Wallace DC (1996) Classification of European mtDNAs from an analysis of three European populations. Genetics 144(4):1835\u20131850","journal-title":"Genetics"},{"issue":"1","key":"1035_CR48","doi-asserted-by":"publisher","first-page":"9987","DOI":"10.1038\/s41598-019-46446-8","volume":"9","author":"G Barshad","year":"2019","unstructured":"Barshad G, Zlotnikov-Poznianski N, Gal L, Schuldiner M, Mishmar D (2019) Disease-causing mutations in subunits of OXPHOS complex I affect certain physical interactions. Sci Rep 9(1):9987","journal-title":"Sci Rep"},{"issue":"21","key":"1035_CR49","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1002\/elps.200900294","volume":"30","author":"M Cerezo","year":"2009","unstructured":"Cerezo M, \u010cern\u00fd V, Carracedo \u00c1, Salas A (2009) Applications of MALDI-TOF MS to large-scale human mtDNA population-based studies. Electrophoresis 30(21):3665\u20133673","journal-title":"Electrophoresis"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-01035-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-020-01035-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-01035-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T19:36:16Z","timestamp":1631820976000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-020-01035-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1186\/s40478-020-01035-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.10.196097","asserted-by":"object"}]},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"12 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Mayo Clinic Institutional Review Board and individual written consent was obtained from all participants, or their next of kin, prior to commencement.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ZKW serves as PI or Co-PI on Abbvie, Inc. (M15-562 and M15-563), Biogen, Inc. (228PD201) Grant, and Biohaven Pharmaceuticals, Inc. (BHV4157-206 and BHV3241-301). He serves as PI of the Mayo Clinic American Parkinson Disease Association (APDA) Information and Referral Center, and as Co-PI of the Mayo Clinic APDA Center for Advanced Research. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}